Patients with the most frequent AEs (occurring in 4 or more patients) by preferred terms (safety population)
Preferred term . | Safety population (n = 28) . | CTCAE grade 1/2 . | CTCAE grade ≥3 . |
---|---|---|---|
Pyrexia | 15 (53.6) | 14 (50.0) | 1 (3.6) |
Chills | 11 (39.3) | 11 (39.3) | 0 (0.0) |
Headache | 8 (28.6) | 8 (28.6) | 0 (0.0) |
Nausea | 5 (17.9) | 5 (17.9) | 0 (0.0) |
Nasopharyngitis | 5 (17.9) | 5 (17.9) | 0 (0.0) |
Vomiting | 4 (14.3) | 4 (14.3) | 0 (0.0) |
Pneumonia | 4 (14.3) | 0 (0.0) | 4 (14.3) |
Infusion reaction | 4 (14.3) | 4 (14.3) | 0 (0.0) |
Rash | 4 (14.3) | 4 (14.3) | 0 (0.0) |
Preferred term . | Safety population (n = 28) . | CTCAE grade 1/2 . | CTCAE grade ≥3 . |
---|---|---|---|
Pyrexia | 15 (53.6) | 14 (50.0) | 1 (3.6) |
Chills | 11 (39.3) | 11 (39.3) | 0 (0.0) |
Headache | 8 (28.6) | 8 (28.6) | 0 (0.0) |
Nausea | 5 (17.9) | 5 (17.9) | 0 (0.0) |
Nasopharyngitis | 5 (17.9) | 5 (17.9) | 0 (0.0) |
Vomiting | 4 (14.3) | 4 (14.3) | 0 (0.0) |
Pneumonia | 4 (14.3) | 0 (0.0) | 4 (14.3) |
Infusion reaction | 4 (14.3) | 4 (14.3) | 0 (0.0) |
Rash | 4 (14.3) | 4 (14.3) | 0 (0.0) |
Data are presented as n (%) of patients.